ALK-2 EVs
€1,400.00
Tax excluded
EV bioengineered with human ALK-2 receptor
ALK-2 EVs, innovative bioengineered EVs harbouring ALK-2 receptor (human Activin receptor-like kinase 2)
ALK-2 EVs are produced by human embryonic kidney (HEK) 293T cells and purified according to in-EV purification process. These pure EVs are characterised using standardised quality controls. ALK-2 receptor is targeted to the EV membrane using Ciloa technology, which does not overexpress or modify natural EV proteins.
ALK-2 EVs are interesting tools that can be used to:
- Study molecular interactions with ligands, specific antibodies or small molecules
- Characterise ALK-2 receptor using technologies like SPR or other
Specifications
| Total protein quantity of pure EVs | 50 µg |
| Particle number (Nano-flow cytometry) | ≥ 1E10 particles |
| Particle size (Nano-flow cytometry) | Median size of 60-70 nm |
| Source | HEK293T cells |
| Buffer | PBS 1X – BSA 10 µg/mL |
| Storage | Store sterile at +4°C up to 6 months |
Strengths of ALK-2 EVs
- 100% fully native receptor embedded with its right topology on EV membrane.
- Bioengineered EVs using Ciloa technology, no overexpression or modification of natural EV proteins.
- Storage at +4°C, in a simple buffer, for several months when kept sterile.
X138_50